Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
GMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$51.79 - $94.93
Previous CloseN/A
Volume442.39K
Average Volume (3M)1.25M
Market Cap
$7.59B
Enterprise Value$7.95B
Total Cash (Recent Filing)$229.45M
Total Debt (Recent Filing)$121.10M
Price to Earnings (P/E)21.7
Beta0.91
Next Earnings
Nov 11, 2025EPS Estimate
0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.86
Shares Outstanding112,620,210
10 Day Avg. Volume1,022,701
30 Day Avg. Volume1,251,307
Financial Highlights & Ratios
PEG Ratio-3.60
Price to Book (P/B)2.69
Price to Sales (P/S)4.46
P/FCF Ratio27.70
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue3.03
Enterprise Value/Gross Profit4.82
Enterprise Value/Ebitda12.84
Forecast
1Y Price Target
$83.00Price Target Upside47.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
EarningsGMED's Q2 EPS was well ahead of consensus, providing a strong positive signal to investors.
GuidanceThe reaffirmation of FY25 revenue and EPS guidance suggests confidence in the company's future performance.
InnovationGMED received FDA clearance for Excelsius XR, showcasing the company's commitment to innovation in the musculoskeletal technology space.
Bears Say
Competitive LandscapeThe CEO transition raises questions about the stability and future direction of the company amid competitive pressures in the spine industry.
Growth ExpectationsExpectations for Enabling Tech are lowered due to commentary and concerns about a potentially prolonged capital cycle.
Operational ChallengesThere is a need for a significant step-up in growth in the second half of FY25, raising concerns about whether the current growth rate sets a new low bar.
Globus Medical News
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $51.79 and its highest was $94.93 in the past 12 months.
What is Globus Medical’s market cap?
Globus Medical’s market cap is $7.59B.
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Nov 11, 2025 which is in 53 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Aug 07, 2025. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.753 by $0.107.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is 0.78.
How many shares outstanding does Globus Medical have?
Globus Medical has 112,620,210 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.86 in its last earnings report, beating expectations of $0.753. Following the earnings report the stock price went up 8.471%.
Which hedge fund is a major shareholder of Globus Medical?
Currently, no hedge funds are holding shares in GMED
Globus Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$83.00 (47.63% Upside)
$83.00 (47.63% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 872.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.92%
12-Months-Change
Fundamentals
Return on Equity
8.62%
Trailing 12-Months
Asset Growth
-0.65%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
GMED Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call depicts a strong quarter for Globus Medical, highlighted by significant revenue growth, a successful integration of Nevro, and continued innovation. Despite some challenges in international markets and lingering supply chain issues, the overall performance and future outlook appear positive.View all GMED earnings summariesGMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
GMED Stock 12 Month Forecast
Average Price Target
$83.00
▲(47.63% Upside)
Technical Analysis
Boston Scientific
―
Koninklijke Philips
―
Smith & Nephew Snats
―
Stryker
―
Zimmer Biomet Holdings
―
Ownership Overview
0.72% Insiders
32.56% Mutual Funds
38.70% Other Institutional Investors
6.29% Public Companies and
Individual Investors